Showing results (461-470 of 671) with videos related to

Sort By:
Pageof 68
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 14, 2020
Altered Regulation of HIF-1α in Naive- and Drug-Resistant EGFR-Mutant NSCLC: Implications for a Vascular Endothelial Growth Factor-Dependent PhenotypeMonique B Nilsson, Jacqulyne Robichaux, Matthew H Herynk, et al.
Molecular Cell|September 23, 2021
NSD2 dimethylation at H3K36 promotes lung adenocarcinoma pathogenesisDeepanwita Sengupta, Liyong Zeng, Yumei Li, et al.
Molecular Cancer Therapeutics|July 31, 2019
Tyrosine Threonine Kinase Inhibition Eliminates Lung Cancers by Augmenting Apoptosis and PolyploidyLin Zheng, Zibo Chen, Masanori Kawakami, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 20, 2019
PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung CancerMarcelo V Negrao, Vincent K Lam, Alexandre Reuben, et al.
British Journal of Cancer|May 17, 2024
Epigenetic activation of SOX11 is associated with recurrence and progression of ductal carcinoma in situ to invasive breast cancerWarapen Treekitkarnmongkol, Vandna Shah, Kazuharu Kai, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|November 28, 2021
Effector memory cytotoxic CD3<sup>+</sup>/CD8<sup>+</sup>/CD45RO<sup>+</sup> T cells are predictive of good survival and a lower risk of recurrence in triple-negative breast cancerXiangjie Sun, Jie Zhai, Baohua Sun, et al.
Cancer Research|September 7, 2018
HORMAD1 Is a Negative Prognostic Indicator in Lung Adenocarcinoma and Specifies Resistance to Oxidative and Genotoxic StressBrandt A Nichols, Nathaniel W Oswald, Elizabeth A McMillan, et al.
Pageof 68